ARTICLE | Clinical News
AnervaX therapeutic vaccine: Started Phase I trial
January 24, 1994 8:00 AM UTC
Anergen Inc. (ANRG), Redwood City, Calif. Product: AnervaX therapeutic vaccine, consisting of a short peptide of a locus in the class II major histocompatibility complex protein, to block presentation...